Bruce Booth - Jun 8, 2022 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role: Director
Signature: /s/ Bruce Booth
Stock symbol: AVRO
Transactions as of: Jun 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/10/2022, 04:36 PM
Previous filing: Mar 3, 2022
Next filing: Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVRO	Stock Option (Right to Buy)	Award	$0	+17.5K		$0.00	17.5K	Jun 8, 2022	Common Stock	17.5K	$1.06	Direct	F1, F2
transaction	AVRO	Stock Option (Right to Buy)	Award	$0	+17.5K		$0.00	17.5K	Jun 8, 2022	Common Stock	17.5K	$1.06	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.
F2	This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Content

The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.

This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.